Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

toolsTechCrunch AINov 17, 2026

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 billion in a Series C funding round.

Impact: MediumConfidence: MediumNovelty: Material
toolstechcrunch-ai

See the whole story

Read the original on TechCrunch AI

Sens.ai aggregates and assesses published reporting. The assessment above is machine generated; the original source is authoritative.